Clinical Trial: A Study of Single-dose MY008211A in Healthy Adults
Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Condition: Paroxysmal Nocturnal Hemoglobinuria
Study Type: Interventional
Official Title: A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Doses Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic/Pharmacodynamics Characteristics of MY008211A Ta
Brief Summary:
The trial is the first human trial. The safety, tolerability, PK and PD of MY008211A Tablets will be evaluated in healthy subjects.
Read more